Clin Mol Hepatol.  2016 Mar;22(1):188-191. 10.3350/cmh.2016.22.1.188.

Liver metastasis of meningeal hemangiopericytoma: a study of 5 cases

Affiliations
  • 1Department of Pathology and State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China. reginalo@pathology.hku.hk
  • 2Department of Pathology, Dartmouth-Hitchcock Medical Center, Cleveland, USA.
  • 3Robert J. Tomsich Pathology & Laboratory Medicine Institute and Department of Cancer Biology, Cleveland Clinic and Lerner Research Institute, Hanover, USA.

Abstract

Mesenchymal tumors in the liver, whether primary or metastatic, are rare. Meningeal hemangiopericytoma (HPC) is characteristically associated with delayed metastasis and the liver is one of the most common sites. Despite its consistent histological features, a pathological diagnosis of HPC in the liver is sometimes not straightforward due to its rarity and usually remote medical history of the primary meningeal tumor. In this report, the clinicopathological features of 5 cases of metastatic HPC to the liver were reviewed and described.

Keyword

Hemangiopericytoma; Liver; Metastasis

MeSH Terms

Adult
Female
Hemangiopericytoma/*pathology
Humans
Liver/pathology
Liver Neoplasms/*pathology/secondary
Male
Meningeal Neoplasms/*pathology
Middle Aged
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr